 | • レポートコード：GIR-2104Z05242 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エストラジオール経皮システムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エストラジオール経皮システムの種類別市場規模（1日0.025mg、1日0.0375mg、1日0.05mg、1日0.075mg、1日0.1mg）、用途別市場規模（ほてり、閉経後骨粗鬆症予防、低エストロゲン症治療、中等度～重度血管運動症状、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エストラジオール経皮システムの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Allergan、Bayer、Noven Therapeutics、Mylan、Vertical Pharmaceuticals、Perrigo Pharma International ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：1日0.025mg、1日0.0375mg、1日0.05mg、1日0.075mg、1日0.1mg ・用途別分析2016年-2026年：ほてり、閉経後骨粗鬆症予防、低エストロゲン症治療、中等度～重度血管運動症状、その他 ・エストラジオール経皮システムの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エストラジオール経皮システムのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エストラジオール経皮システムのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エストラジオール経皮システムの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エストラジオール経皮システムの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Estradiol Transdermal System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Estradiol Transdermal System size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Estradiol Transdermal System market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Estradiol Transdermal System market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
0.025 mg per day
0.0375 mg per day
0.05 mg per day
0.075 mg per day
0.1 mg per day
Market segment by Application, can be divided into
Hot Flashes
Prevention of Postmenopausal Osteoporosis
Treatment of Hypoestrogenism
Moderate-To-Severe Vasomotor Symptoms
Others
Market segment by players, this report covers
Novartis
Allergan
Bayer
Noven Therapeutics
Mylan
Vertical Pharmaceuticals
Perrigo Pharma International
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Estradiol Transdermal System
1.2 Classification of Estradiol Transdermal System by Type
1.2.1 Overview: Global Estradiol Transdermal System Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Estradiol Transdermal System Revenue Market Share by Type in 2020
1.2.3 0.025 mg per day
1.2.4 0.0375 mg per day
1.2.5 0.05 mg per day
1.2.6 0.075 mg per day
1.2.7 0.1 mg per day
1.3 Global Estradiol Transdermal System Market by Application
1.3.1 Overview: Global Estradiol Transdermal System Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hot Flashes
1.3.3 Prevention of Postmenopausal Osteoporosis
1.3.4 Treatment of Hypoestrogenism
1.3.5 Moderate-To-Severe Vasomotor Symptoms
1.3.6 Others
1.4 Global Estradiol Transdermal System Market Size & Forecast
1.5 Global Estradiol Transdermal System Market Size and Forecast by Region
1.5.1 Global Estradiol Transdermal System Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Estradiol Transdermal System Market Size by Region, (2016-2021)
1.5.3 North America Estradiol Transdermal System Market Size and Prospect (2016-2026)
1.5.4 Europe Estradiol Transdermal System Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Estradiol Transdermal System Market Size and Prospect (2016-2026)
1.5.6 South America Estradiol Transdermal System Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Estradiol Transdermal System Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Estradiol Transdermal System Market Drivers
1.6.2 Estradiol Transdermal System Market Restraints
1.6.3 Estradiol Transdermal System Trends Analysis
2 Company Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Estradiol Transdermal System Product and Solutions
2.1.4 Novartis Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis Recent Developments and Future Plans
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business
2.2.3 Allergan Estradiol Transdermal System Product and Solutions
2.2.4 Allergan Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Allergan Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Estradiol Transdermal System Product and Solutions
2.3.4 Bayer Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Noven Therapeutics
2.4.1 Noven Therapeutics Details
2.4.2 Noven Therapeutics Major Business
2.4.3 Noven Therapeutics Estradiol Transdermal System Product and Solutions
2.4.4 Noven Therapeutics Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Noven Therapeutics Recent Developments and Future Plans
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Estradiol Transdermal System Product and Solutions
2.5.4 Mylan Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Mylan Recent Developments and Future Plans
2.6 Vertical Pharmaceuticals
2.6.1 Vertical Pharmaceuticals Details
2.6.2 Vertical Pharmaceuticals Major Business
2.6.3 Vertical Pharmaceuticals Estradiol Transdermal System Product and Solutions
2.6.4 Vertical Pharmaceuticals Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Vertical Pharmaceuticals Recent Developments and Future Plans
2.7 Perrigo Pharma International
2.7.1 Perrigo Pharma International Details
2.7.2 Perrigo Pharma International Major Business
2.7.3 Perrigo Pharma International Estradiol Transdermal System Product and Solutions
2.7.4 Perrigo Pharma International Estradiol Transdermal System Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Perrigo Pharma International Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Estradiol Transdermal System Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Estradiol Transdermal System Players Market Share
3.2.2 Top 10 Estradiol Transdermal System Players Market Share
3.2.3 Market Competition Trend
3.3 Estradiol Transdermal System Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Estradiol Transdermal System Revenue and Market Share by Type (2016-2021)
4.2 Global Estradiol Transdermal System Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Estradiol Transdermal System Revenue Market Share by Application (2016-2021)
5.2 Estradiol Transdermal System Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Estradiol Transdermal System Revenue by Type (2016-2026)
6.2 North America Estradiol Transdermal System Revenue by Application (2016-2026)
6.3 North America Estradiol Transdermal System Market Size by Country
6.3.1 North America Estradiol Transdermal System Revenue by Country (2016-2026)
6.3.2 United States Estradiol Transdermal System Market Size and Forecast (2016-2026)
6.3.3 Canada Estradiol Transdermal System Market Size and Forecast (2016-2026)
6.3.4 Mexico Estradiol Transdermal System Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Estradiol Transdermal System Revenue by Type (2016-2026)
7.2 Europe Estradiol Transdermal System Revenue by Application (2016-2026)
7.3 Europe Estradiol Transdermal System Market Size by Country
7.3.1 Europe Estradiol Transdermal System Revenue by Country (2016-2026)
7.3.2 Germany Estradiol Transdermal System Market Size and Forecast (2016-2026)
7.3.3 France Estradiol Transdermal System Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Estradiol Transdermal System Market Size and Forecast (2016-2026)
7.3.5 Russia Estradiol Transdermal System Market Size and Forecast (2016-2026)
7.3.6 Italy Estradiol Transdermal System Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Estradiol Transdermal System Revenue by Type (2016-2026)
8.2 Asia-Pacific Estradiol Transdermal System Revenue by Application (2016-2026)
8.3 Asia-Pacific Estradiol Transdermal System Market Size by Region
8.3.1 Asia-Pacific Estradiol Transdermal System Revenue by Region (2016-2026)
8.3.2 China Estradiol Transdermal System Market Size and Forecast (2016-2026)
8.3.3 Japan Estradiol Transdermal System Market Size and Forecast (2016-2026)
8.3.4 South Korea Estradiol Transdermal System Market Size and Forecast (2016-2026)
8.3.5 India Estradiol Transdermal System Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Estradiol Transdermal System Market Size and Forecast (2016-2026)
8.3.7 Australia Estradiol Transdermal System Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Estradiol Transdermal System Revenue by Type (2016-2026)
9.2 South America Estradiol Transdermal System Revenue by Application (2016-2026)
9.3 South America Estradiol Transdermal System Market Size by Country
9.3.1 South America Estradiol Transdermal System Revenue by Country (2016-2026)
9.3.2 Brazil Estradiol Transdermal System Market Size and Forecast (2016-2026)
9.3.3 Argentina Estradiol Transdermal System Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Estradiol Transdermal System Revenue by Type (2016-2026)
10.2 Middle East & Africa Estradiol Transdermal System Revenue by Application (2016-2026)
10.3 Middle East & Africa Estradiol Transdermal System Market Size by Country
10.3.1 Middle East & Africa Estradiol Transdermal System Revenue by Country (2016-2026)
10.3.2 Turkey Estradiol Transdermal System Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Estradiol Transdermal System Market Size and Forecast (2016-2026)
10.3.4 UAE Estradiol Transdermal System Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Estradiol Transdermal System Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Estradiol Transdermal System Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Estradiol Transdermal System Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Estradiol Transdermal System Revenue (USD Million) by Region (2016-2021)
Table 5. Global Estradiol Transdermal System Revenue Market Share by Region (2021-2026)
Table 6. Novartis Corporate Information, Head Office, and Major Competitors
Table 7. Novartis Major Business
Table 8. Novartis Estradiol Transdermal System Product and Solutions
Table 9. Novartis Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Allergan Corporate Information, Head Office, and Major Competitors
Table 11. Allergan Major Business
Table 12. Allergan Estradiol Transdermal System Product and Solutions
Table 13. Allergan Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Estradiol Transdermal System Product and Solutions
Table 17. Bayer Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Noven Therapeutics Corporate Information, Head Office, and Major Competitors
Table 19. Noven Therapeutics Major Business
Table 20. Noven Therapeutics Estradiol Transdermal System Product and Solutions
Table 21. Noven Therapeutics Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Mylan Corporate Information, Head Office, and Major Competitors
Table 23. Mylan Major Business
Table 24. Mylan Estradiol Transdermal System Product and Solutions
Table 25. Mylan Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Vertical Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. Vertical Pharmaceuticals Major Business
Table 28. Vertical Pharmaceuticals Estradiol Transdermal System Product and Solutions
Table 29. Vertical Pharmaceuticals Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Perrigo Pharma International Corporate Information, Head Office, and Major Competitors
Table 31. Perrigo Pharma International Major Business
Table 32. Perrigo Pharma International Estradiol Transdermal System Product and Solutions
Table 33. Perrigo Pharma International Estradiol Transdermal System Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Estradiol Transdermal System Revenue (USD Million) by Players (2019-2021)
Table 35. Global Estradiol Transdermal System Revenue Share by Players (2019-2021)
Table 36. Breakdown of Estradiol Transdermal System by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Estradiol Transdermal System Players Head Office, Products and Services Provided
Table 38. Estradiol Transdermal System Mergers & Acquisitions in the Past Five Years
Table 39. Estradiol Transdermal System New Entrants and Expansion Plans
Table 40. Global Estradiol Transdermal System Revenue (USD Million) by Type (2016-2021)
Table 41. Global Estradiol Transdermal System Revenue Share by Type (2016-2021)
Table 42. Global Estradiol Transdermal System Revenue Forecast by Type (2021-2026)
Table 43. Global Estradiol Transdermal System Revenue by Application (2016-2021)
Table 44. Global Estradiol Transdermal System Revenue Forecast by Application (2021-2026)
Table 45. North America Estradiol Transdermal System Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Estradiol Transdermal System Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Estradiol Transdermal System Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Estradiol Transdermal System Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Estradiol Transdermal System Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Estradiol Transdermal System Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Estradiol Transdermal System Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Estradiol Transdermal System Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Estradiol Transdermal System Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Estradiol Transdermal System Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Estradiol Transdermal System Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Estradiol Transdermal System Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Estradiol Transdermal System Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Estradiol Transdermal System Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Estradiol Transdermal System Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Estradiol Transdermal System Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Estradiol Transdermal System Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Estradiol Transdermal System Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Estradiol Transdermal System Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Estradiol Transdermal System Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Estradiol Transdermal System Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Estradiol Transdermal System Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Estradiol Transdermal System Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Estradiol Transdermal System Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Estradiol Transdermal System Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Estradiol Transdermal System Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Estradiol Transdermal System Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Estradiol Transdermal System Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Estradiol Transdermal System Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Estradiol Transdermal System Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Estradiol Transdermal System Picture
Figure 2. Global Estradiol Transdermal System Revenue Market Share by Type in 2020
Figure 3. 0.025 mg per day
Figure 4. 0.0375 mg per day
Figure 5. 0.05 mg per day
Figure 6. 0.075 mg per day
Figure 7. 0.1 mg per day
Figure 8. Estradiol Transdermal System Revenue Market Share by Application in 2020
Figure 9. Hot Flashes Picture
Figure 10. Prevention of Postmenopausal Osteoporosis Picture
Figure 11. Treatment of Hypoestrogenism Picture
Figure 12. Moderate-To-Severe Vasomotor Symptoms Picture
Figure 13. Others Picture
Figure 14. Global Estradiol Transdermal System Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 15. Global Estradiol Transdermal System Revenue and Forecast (2016-2026) & (USD Million)
Figure 16. Global Estradiol Transdermal System Revenue Market Share by Region (2016-2026)
Figure 17. Global Estradiol Transdermal System Revenue Market Share by Region in 2020
Figure 18. North America Estradiol Transdermal System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Europe Estradiol Transdermal System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Asia-Pacific Estradiol Transdermal System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. South America Estradiol Transdermal System Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Estradiol Transdermal System Market Drivers
Figure 23. Estradiol Transdermal System Market Restraints
Figure 24. Estradiol Transdermal System Market Trends
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Allergan Recent Developments and Future Plans
Figure 27. Bayer Recent Developments and Future Plans
Figure 28. Noven Therapeutics Recent Developments and Future Plans
Figure 29. Mylan Recent Developments and Future Plans
Figure 30. Vertical Pharmaceuticals Recent Developments and Future Plans
Figure 31. Perrigo Pharma International Recent Developments and Future Plans
Figure 33. Global Estradiol Transdermal System Revenue Share by Players in 2020
Figure 34. Estradiol Transdermal System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Estradiol Transdermal System Revenue Market Share in 2020
Figure 36. Global Top 10 Players Estradiol Transdermal System Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Estradiol Transdermal System Revenue Share by Type in 2020
Figure 39. Global Estradiol Transdermal System Market Share Forecast by Type (2021-2026)
Figure 40. Global Estradiol Transdermal System Revenue Share by Application in 2020
Figure 41. Global Estradiol Transdermal System Market Share Forecast by Application (2021-2026)
Figure 42. North America Estradiol Transdermal System Sales Market Share by Type (2016-2026)
Figure 43. North America Estradiol Transdermal System Sales Market Share by Application (2016-2026)
Figure 44. North America Estradiol Transdermal System Revenue Market Share by Country (2016-2026)
Figure 45. United States Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Estradiol Transdermal System Sales Market Share by Type (2016-2026)
Figure 49. Europe Estradiol Transdermal System Sales Market Share by Application (2016-2026)
Figure 50. Europe Estradiol Transdermal System Revenue Market Share by Country (2016-2026)
Figure 51. Germany Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Estradiol Transdermal System Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Estradiol Transdermal System Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Estradiol Transdermal System Revenue Market Share by Region (2016-2026)
Figure 59. China Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Estradiol Transdermal System Sales Market Share by Type (2016-2026)
Figure 66. South America Estradiol Transdermal System Sales Market Share by Application (2016-2026)
Figure 67. South America Estradiol Transdermal System Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Estradiol Transdermal System Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Estradiol Transdermal System Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Estradiol Transdermal System Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Estradiol Transdermal System Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のエストラジオール経皮システム市場規模・現状・予測（2021年-2027年） Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching…- 世界のエストラジオール経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Estradiol Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界のエチニルエストラジオールとレボノルゲストレル市場 2021：企業別、地域別、種類・用途別 The Ethinyl Estradiol and Levonorgestrel market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 世界のニコチン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Nicotine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…
- 世界のリバスチグミン経皮パッチ市場 2021：企業別、地域別、種類・用途別 The Rivastigmine Transdermal Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…